Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus

By Arribillaga L.   de Cerio A.L.D.   Sarobe P.   Casares N.   Gorraiz M.   Vales A.   Bruna-Romero O.   Borras-Cuesta F.   Paranhos-Baccala G.   Prieto J.   Ruiz J.   Lasarte J.J.  

Vaccine, Vol. 21, Iss. 3, 2002-12 ,pp. : 202-210

Elsevier

Access to resources Recommend Favorite

Protective effects against simian immunodeficiency virus agm (SIVagm) infection in cynomolgus monkeys immunized with a recombinant vaccinia virus expressing the SIVagm envelope gene

By Ibuki K.   Ido E.   Funahashi S.-i.   Miura T.   Hayami M.   Shida H.  

Vaccine, Vol. 18, Iss. 5, 1999-10 ,pp. : 511-516

Elsevier

Access to resources Recommend Favorite

Protective immunity against foot-and-mouth disease virus induced by a recombinant vaccinia virus

By Berinstein A.   Tami C.   Taboga O.   Smitsaart E.   Carrillo E.  

Vaccine, Vol. 18, Iss. 21, 2000-04 ,pp. : 2231-2238

Elsevier

Access to resources Recommend Favorite

Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model

By Wyatt L.S.   Shors S.T.   Murphy B.R.   Moss B.  

Vaccine, Vol. 14, Iss. 15, 1996-10 ,pp. : 1451-1458

Elsevier

Access to resources Recommend Favorite

Kinetics of formation of neutralizing antibodies against vaccinia virus following re-vaccination

By Stienlauf S.   Shoresh M.   Solomon A.   Lublin-Tennenbaum T.   Atsmon Y.   Meirovich Y.   Katz E.  

Vaccine, Vol. 17, Iss. 3, 1999-02 ,pp. : 201-204

Elsevier

Access to resources Recommend Favorite